ANRO Alto Neuroscience Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: ANRO

Price (delayed)

$32.3

Market cap

$1.27B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.42

Enterprise value

$1.05B

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4
Highlights
The debt has declined by 17% year-on-year
ANRO's equity has soared by 78% YoY but it is down by 10% QoQ
The company's net income fell by 30% YoY and by 13% QoQ
ANRO's quick ratio is down by 27% since the previous quarter and by 19% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.altoneuroscience.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ANRO

ANRO stock price

How has the Alto Neuroscience stock price performed over time
Intraday
10.69%
1 week
13.45%
1 month
15.23%
1 year
931.95%
YTD
81.46%
QTD
22.39%

Financial performance

How have Alto Neuroscience's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$88.27M
Net income
-$84.24M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 30% YoY and by 13% QoQ
Alto Neuroscience's operating income has decreased by 26% YoY and by 13% QoQ

Price vs fundamentals

How does ANRO's price correlate with its fundamentals

Growth

What is Alto Neuroscience's growth rate over time

Valuation

What is Alto Neuroscience stock price valuation
P/E
N/A
P/B
5.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ANRO's equity has soared by 78% YoY but it is down by 10% QoQ
The price to book (P/B) is 72% more than the last 4 quarters average of 3.0

Efficiency

How efficient is Alto Neuroscience business performance
Alto Neuroscience's ROIC has decreased by 34% YoY and by 32% from the previous quarter
The return on assets has declined by 5% year-on-year
The ROE has decreased by 3.8% YoY

Dividends

What is ANRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANRO.

Financial health

How did Alto Neuroscience financials performed over time
ANRO's total assets has surged by 61% year-on-year but it is down by 8% since the previous quarter
ANRO's current ratio is down by 28% since the previous quarter and by 19% year-on-year
The debt is 90% smaller than the equity
ANRO's equity has soared by 78% YoY but it is down by 10% QoQ
ANRO's debt to equity has plunged by 52% YoY but it is up by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.